Buy or sell RefleXion Medical stock pre IPO via an EquityZen fund
EquityZen is a marketplace for shares of proven pre IPO tech companies
RefleXion Medical Stock
Biologically-Guided Radiotherapy Systems for Patients with Cancer
About RefleXion Medical Stock
RefleXion Medical is a privately held medical device company developing the first biology-guided radiation therapy system for cancer treatment. By leveraging Positron Emission Tomography (PET) in a novel way, RefleXion's patented technology will allow tumors to continuously signal their location during treatment and potentially revolutionize the practice of radiation oncology. Early validation of RefleXion's technology was funded by the National Cancer Institute. RefleXion is backed by premier investors; Sofinnova Partners, KCK, Pfizer, Venrock and Johnson & Johnson Innovation.
Investors
Ally Bridge Group
GT Healthcare Capital Partners
Johnson & Johnson Innovation
Pfizer Venture Investments
PSP Investments
Sofinnova Partners
The Rise Fund
T. Rowe Price
One97, Flipkart, WeWork, Cruise, Airbnb, Rivian, Magic Leap, Nuro, Caris Life Sciences, Vroom
Funding History
| April 2014 | $11.7M |
|---|---|
| April 2016 | $52.1M |
| March 2018 | $103M |
| April 2020 | $125M |
Management
Chief Executive Officer
Todd Powell
Chief Financial Officer
Martyn Webster
Chief Technology Officer
Sam Mazin
Press
businesswire - May, 27 2021
madisonstartups - Jan, 8 2021
itnonline - Jun, 1 2020
healthcareglobal - Jun, 1 2020
crunchbase - Apr, 17 2020
finsmes - Apr, 16 2020
DOTmed.com - Oct, 24 2018
mobihealthnews - Mar, 22 2018
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
